...
首页> 外文期刊>American journal of psychiatry >Discrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trial.
【24h】

Discrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trial.

机译:在一项双盲,随机临床试验中,SAMe治疗的患者的应答和缓解率差异。

获取原文
获取原文并翻译 | 示例

摘要

To the Editor: In the August 2010 issue of the Journal, George I. Papakostas, M.D., et al. (1), appear to have inadvertently made a calculation error, which has affected the results of their data. The authors stated that "response rates for SAMe-treated patients versus placebo-treated patients were 36.1% versus 17.6%, respectively, while remission rates were 25.8% versus 11.7%, respectively" (1, p. 946).Our calculations, based on the data presented in the article, are inconsistent with the aforementioned percentages. The quoted percentage is 36.1% for SAMe plus antidepressant treatment among responders, whereas the actual number of responders indicated on page 945 is 18/39, or 46.1%.
机译:致编辑:在2010年8月的《日刊》上,乔治一世·帕帕科斯塔斯医学博士等人。 (1),似乎无意中造成了计算错误,从而影响了其数据结果。作者指出,“接受SAMe治疗的患者与接受安慰剂治疗的患者的缓解率分别为36.1%和17.6%,而缓解率分别为25.8%和11.7%”(1,第946页)。在文章中提供的数据上,与上述百分比不一致。响应者中SAMe加抗抑郁药的报价百分比为36.1%,而第945页上指出的实际响应者数量为18/39,或46.1%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号